[1]王爽,李晓鹏.房水中内皮素-1、超氧化物歧化酶与糖尿病视网膜病变患者术后视力残疾的关系[J].眼科新进展,2023,43(3):203-207.[doi:10.13389/j.cnki.rao.2023.0041]
　WANG Shuang,LI Xiaopeng.Study on the relationship between endothelin-1, superoxide dismutase in aqueous humor and postoperative visual disability in diabetic retinopathy patients[J].Recent Advances in Ophthalmology,2023,43(3):203-207.[doi:10.13389/j.cnki.rao.2023.0041]
点击复制

房水中内皮素-1、超氧化物歧化酶与糖尿病视网膜病变患者术后视力残疾的关系/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
43卷
期数:
2023年3期
页码:
203-207
栏目:
应用研究
出版日期:
2023-03-05

文章信息/Info

Title:
Study on the relationship between endothelin-1, superoxide dismutase in aqueous humor and postoperative visual disability in diabetic retinopathy patients
作者:
王爽; 李晓鹏
453003　河南省新乡市，新乡医学院第三附属医院眼科
Author(s):
WANG Shuang; LI Xiaopeng
Department of Ophthalmology,the Third Afiliated Hospital of Xinxiang Medical University,Xixiang 453003,Henan Province,China
关键词:
糖尿病视网膜病变; 玻璃体切割术; 视力残疾; 内皮素-1; 超氧化物歧化酶
Keywords:
diabetic retinopathy;  vitrectomy;  visual disability;  endothelin-1;  superoxide dismutase
分类号:
R774.1
DOI:
10.13389/j.cnki.rao.2023.0041
文献标志码:
A
摘要:
目的　分析房水中内皮素（ET）-1、超氧化物歧化酶（SOD）与糖尿病视网膜病变（DR）患者玻璃体切割术后视力残疾的关系，探讨能够改善DR患者术后视力的治疗靶点。
方法　前瞻性研究。纳入2019年2月至2021年1月在我院眼科接受玻璃体切割术治疗的112例（112眼）DR患者进行研究，以术后随访1年内裸眼视力检查结果进行分组，分为视力残疾组和视力良好组。入院检查项目包括血糖［空腹血糖（FBG）、餐后2 h血糖（2hBG）、糖化血红蛋白（HbAlc）］、肝肾功能［血肌酐（Scr）、总胆红素（TBIL）］、D-二聚体（D-D）、C反应蛋白（CRP）、ET-1、SOD，根据检查结果，分析患者房水中ET-1、SOD及相关指标与DR患者术后1年内视力残疾的关系，并检验房水中ET-1、SOD对DR患者术后1年内视力残疾的预测效能。
结果　入组的112例DR患者中，随访期间失访2例，退出研究1例，中风死亡1例，剩余108例患者随访时间为4~12个月，28例患者接受裸眼视力检查时诊断为视力残疾，发生率为25.93%。视力残疾组患者重度增生病变占比多于视力良好组，视力残疾组患者血浆D-D、CRP，血清Scr、TBIL水平均高于视力良好组，视力残疾组患者房水中ET-1水平高于视力良好组，视力残疾组患者SOD水平低于视力良好组，差异均有统计学意义（均为P<0.05）。构建Logistic回归模型，重度增生，血浆D-D、CRP高表达，房水中ET-1高表达、SOD低表达均能够增加DR患者术后1年内视力残疾的风险（均为P<0.05）。绘制ROC曲线，房水中ET-1、SOD单独及联合预测术后1年内视力残疾风险的AUC值分别为0.806、0.816、0.870。
结论　DR患者接受玻璃体切割术治疗后1年容易发生视力残疾，房水中ET-1高表达、SOD低表达均能够增加术后1年内视力残疾的风险，房水中ET-1、SOD能够作为 DR患者术后1年内视力残疾的预测因子。
Abstract:
Objective　To analyze the relationship between endothelin-1 (ET-1), superoxide dismutase (SOD) in aqueous humor and visual disability of patients with diabetic retinopathy (DR) after vitrectomy and to explore the therapeutic targets that can improve the postoperative visual acuity of DR patients.
Methods　A prospective study was conducted on 112 DR patients (112 eyes) who underwent the vitrectomy in the Department of Ophthalmology of our hospital from February 2019 to January 2021. The patients were divided into two groups according to the results of the naked vision examination within one year of follow-up, namely, the visual disability group and the normal visual acuity group. The admission examination items include blood glucose ［fasting blood glucose (FBG),2 h postprandial blood glucose (2hBG), and glycosylated hemoglobin (HbAlc)］, liver and kidney functions ［serum creatinine (Scr) and total bilirubin (TBIL)］, D-dimer (D-D), C-reactive protein (CRP), ET-1， and SOD. According to the examination results, the relationship between ET-1, SOD and related indicators in aqueous humor and visual disability in DR patients within 1 year after surgery was analyzed, and the predictive efficacy of ET-1 and SOD in the aqueous humor on visual disability in DR patients within 1 year after surgery was verified.
Results　Of the 112 DR patients enrolled in the study, 2 were lost during the follow-up period, 1 withdrew from the study, and 1 died of stroke. The remaining 108 patients were followed up for 4-12 months. A total of 28 patients were diagnosed with visual disability upon the naked vision examination, with an incidence of 25.93%. In the visual disability group, the proportion of severe hyperplasia, levels of plasma D-D, CRP, serum Scr, TBIL, and ET-1 in the aqueous humor were higher than those in the normal visual acuity group, and the level of SOD was lower than that in the normal visual acuity group, with statistically significant differences (all P<0.05). A logistic regression model was established. Severe hyperplasia, high expressions of plasma D-D and CRP, as well as ET-1 in the aqueous humor, and low expression of SOD in the aqueous humor could increase the risk of visual disability in DR patients within 1 year after surgery (all P<0.05). The receiver operating characteristic curve was drawn. The areas under the curve that ET-1 and SOD in the aqueous humor alone and jointly predicted the risk of visual disability within 1 year after surgery were 0.806, 0.816 and 0.870, respectively.
Conclusion　DR patients are prone to visual disability one year after vitrectomy. Both high expression of ET-1 and low expression of SOD in the aqueous humor can increase the risk of visual disability within one year after surgery. Thus the ET-1 and SOD in the aqueous humor can be used as predictors of visual disability within one year after surgery in DR patients.

参考文献/References:

［1］　CHELONI R,GANDOLFI S A,SIGNORELLI C,ODONE A.Global prevalence of diabetic retinopathy:protocol for a systematic review and meta-analysis［J］.BMJ Open,2019,9(3):e022188.
［2］　SABANAYAGAM C,BANU R,CHEE M L,LEE R,WANG Y X,TAN G,et al.Incidence and progression of diabetic retinopathy:a systematic review［J］.Lancet Diabetes Endocrinol,2019,7(2):140-149.
［3］　沈朝兰，黄孔乾，崔凌，吕明良，唐芬，钟海彬，等.增殖性糖尿病视网膜病变患者视力预后不良的影响因素分析［J］.国际眼科杂志，2020，20(4):703-706.
SHEN C L,HUANG K Q,CUI L,L M L,TANG F,ZHONG H B,et al.Risk factors influencing prognosis in surgical patients with proliferative diabetic retinopathy［J］.Int Eye Sci,2020，20(4):703-706.
［4］　NIRANJAN G,SRINIVASAN A R,SRIKANTH K,PRUTHU G,REETA R,RAMESH R,et al.Evaluation of circulating plasma VEGF-A,ET-1 and magnesium levels as the predictive markers for proliferative diabetic retinopathy［J］.Indian J Clin Biochem,2019,34(3):352-356.
［5］　TRIST B G,HILTON J B,HARE D J,CROUCH P J,DOUBLE K L.Superoxide dismutase 1 in health and disease:how a frontline antioxidant becomes neurotoxic［J］.Angew Chem Int Ed Engl,2021,60(17):9215-9246.
［6］　颜华，赵家良，管怀进，张静楷.第二次全国残疾人抽样调查视力残疾标准制定的研究［J］.中华眼科杂志，2007，43(11):1055-1056.
YAN H,ZHAO J L,GUAN H J,ZHANG J K.The second national sample survey of the disabled visual disability standard-setting study［J］.Chin J Ophthalmol，2007，43(11):1055-1056.
［7］　金昱，黄国富，赵雁之.严重增殖性糖尿病视网膜病变患者术后疗效及影响因素［J］.国际眼科杂志，2019，19(9):1554-1558.
JIN Y,HUANG G F,ZHAO Y Z.Postoperative efficacy and influencing factors of patients with severe proliferative diabetic retinopathy［J］.Int Eye Sci,2019，19(9):1554-1558.
［8］　SORRENTINO F S,MATTEINI S,BONIFAZZI C,SEBASTIANI A,PARMEGGIANI F.Diabetic retinopathy and endothelin system:microangiopathy versus endothelial dysfunction［J］.Eye(Lond),2018,32(7):1157-1163.
［9］　JAIN A,COFFEY C,MEHROTRA V,FLAMMER J.Endothelin-1 traps as a potential therapeutic tool:from diabetes to beyond?［J］.Drug Discov Today,2019,24(9):1937-1942.
［10］　CHANG W,LAJKO M,FAWZI A A.Endothelin-1 is associated with fibrosis in proliferative diabetic retinopathy membranes［J］.PLoS One,2018,13(1):e0191285.
［11］　KANG H M,HASANUZZAMAN M,KIM S W,KOH H J,LEE S C.Elevated aqueous endothelin-1 concentrations in advanced diabetic retinopathy［J］.PLoS One,2022,17(5):e0268353.
［12］　CHESNOKOVA N B,PAVLENKO T A,BEZNOS O V,GRIGORYEV A V.The role of the endothelin system in the pathogenesis of eye diseases［J］.Vestn Oftalmol,2020,136(1):117-123.
［13］　徐卫星，徐军.糖尿病视网膜病变患者血清同型半胱氨酸、维生素B12及叶酸与氧化应激的关系［J］.眼科新进展，2018，38(6):556-559.
XU W X,XU J.Correladon of serum homocysteine，vitamin B12 and folic acid with oxidative stress in patients with diabetic retinopathy［J］.Rec Adv Ophthalmol,2018，38(6):556-559.
［14］　AHMAD A,AHSAN H.Biomarkers of inflammation and oxidative stress in ophthalmic disorders［J］.J Immunoassay Immunochem,2020,41(3):257-271.

相似文献/References:

[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]董敬远 刘瑶 吴晓艳.玻璃体切割联合白内障手术治疗增生性糖尿病视网膜病变[J].眼科新进展,2012,32(5):000.
[3]张楚 邹玉平 邹秀兰 徐哲 王泳.内窥镜引导玻璃体视网膜手术治疗伴有角膜混浊的外伤性视网膜脱离[J].眼科新进展,2012,32(6):000.
[4]刘刚 马英慧 贾万程.玻璃体切割术联合视网膜光凝或内界膜剥除术治疗黄斑裂孔性视网膜脱离的疗效分析[J].眼科新进展,2012,32(7):000.
[5]刘敬花 李松峰 卢海.23G微创玻璃体切割术在增生性糖尿病视网膜病变治疗中的应用[J].眼科新进展,2012,32(11):000.
[6]王蕊 王兴利 王一.玻璃体切割术治疗球内金属异物并发眼内炎的玻璃体腔填充物的选择[J].眼科新进展,2012,32(11):000.
[7]杨铮 陈彬川 周瑞雅.玻璃体手术后高眼压及其处理[J].眼科新进展,2012,32(11):000.
[8]陈吉婷 李学喜 王志军.两种手术方式取出眼后段磁性异物的对比研究[J].眼科新进展,2012,32(11):000.
[9]张保松.复杂开放性眼外伤手术疗效及其相关影响因素分析[J].眼科新进展,2012,32(12):000.
[10]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[11]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[12]王方 冯乐 惠延年.视网膜光凝和玻璃体手术治疗糖尿病视网膜病变的有效性[J].眼科新进展,2012,32(10):000.
[13]张思伟,柯根杰,顾永昊.有/无填充物微创玻璃体切割术治疗增生性糖尿病视网膜病变合并牵拉性视网膜脱离的疗效比较[J].眼科新进展,2014,34(12):1174.[doi:10.13389/j.cnki.rao.2014.0326]
　ZHANG Si-Wei,KE Gen-Jie,GU Yong-Hao.Efficacy of minimally invasive vitrectomy with/without filler for PDR combined with tractional RD[J].Recent Advances in Ophthalmology,2014,34(3):1174.[doi:10.13389/j.cnki.rao.2014.0326]
[14]周爱意,周陈静,权彦龙,等.眼内填充在增生型糖尿病视网膜病变合并玻璃体出血玻璃体切割术中的作用[J].眼科新进展,2016,36(9):838.[doi:10.13389/j.cnki.rao.2016.0224]
　ZHOU Ai-Yi,ZHOU Chen-Jing,QUAN Yan-Long,et al.Role of intraocular tamponade in vitrectomy for proliferative diabetic retinopathy with vitreous hemorrhage[J].Recent Advances in Ophthalmology,2016,36(3):838.[doi:10.13389/j.cnki.rao.2016.0224]
[15]冯希敏,祁颖,张凤妍,等.玻璃体内注射雷珠单抗联合玻璃体切割术治疗增生型糖尿病视网膜病变的疗效观察[J].眼科新进展,2016,36(11):1079.[doi:10.13389/j.cnki.rao.2016.0288]
　FENG Xi-Min,QI Ying,ZHANG Feng-Yan,et al.Intravitreal injection of ranibizumab combined with vitrectomy for proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2016,36(3):1079.[doi:10.13389/j.cnki.rao.2016.0288]
[16]尹妮,赵帅,朱红娜.康柏西普预处理联合玻璃体切割术治疗增生型糖尿病视网膜病变[J].眼科新进展,2017,37(8):770.[doi:10.13389/j.cnki.rao.2017.0195]
　YIN Ni,ZHAO Shuai,ZHU Hong-Na.Conbercept pre-treatment combined with vitrectomy for proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2017,37(3):770.[doi:10.13389/j.cnki.rao.2017.0195]
[17]龙婷,陈佳,杜磊,等.雷珠单抗联合玻璃体切割术治疗糖尿病视网膜病变合并新生血管性青光眼[J].眼科新进展,2017,37(12):1182.[doi:10.13389/j.cnki.rao.2017.0298]
　LONG Ting,CHEN Jia,DU Lei,et al.Clinical outcomes of ranibizumab combined with vitrectomy in treatment of patients with diabetic retinopathy accompanied by neovascular glaucoma[J].Recent Advances in Ophthalmology,2017,37(3):1182.[doi:10.13389/j.cnki.rao.2017.0298]
[18]郝琳娜,毕春潮.玻璃体手术前视网膜光凝对增生型糖尿病视网膜病变患者预后的影响[J].眼科新进展,2019,39(2):176.[doi:10.13389/j.cnki.rao.2019.0040]
　HAO Lin-Na,BI Chun-Chao.Effect of laser photocoagulation before vitrectomy on prognosis of patients with proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2019,39(3):176.[doi:10.13389/j.cnki.rao.2019.0040]

备注/Memo

备注/Memo:
河南省医学科技攻关计划（联合共建）项目（编号：LHGJ20190492）
更新日期/Last Update: 2023-03-05